DYADIC INTERNATIONAL INC Other Income
DYADIC INTERNATIONAL INC (DYAI) reported Other Income of $1.02 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2024-03-28
- DYADIC INTERNATIONAL INC other income for the quarter ending 2023-12-31 was $0.00.
- DYADIC INTERNATIONAL INC other income for the quarter ending 2023-09-30 was $0.00.
- DYADIC INTERNATIONAL INC other income for the quarter ending 2023-06-30 was $29.00K.
- DYADIC INTERNATIONAL INC other income for the quarter ending 2023-03-31 was $989.00K, a 295.60% increase year-over-year.
- DYADIC INTERNATIONAL INC other income for fiscal 2023 was $1.02M, a 307.20% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC other income for fiscal 2022 was $250.00K.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $29.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.02M 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $29.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.02M 10-Q · filed 2023-11-08 | $1.02M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.02M 10-Q · filed 2023-08-09 | $1.02M derived: sum of 3 quarters · filed 2024-03-28 | $1.02M derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $989.00K 10-Q · filed 2023-05-10 | $989.00K derived: sum of 2 quarters · filed 2024-03-28 | $989.00K derived: sum of 3 quarters · filed 2024-03-28 | $989.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $250.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $250.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $250.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $250.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |